文献速递糖尿病

循环AFABP、FGF21和PEDF水平作为威胁视力糖尿病视网膜病变的预后生物标志物

Circulating AFABP, FGF21, and PEDF Levels as Prognostic Biomarkers of Sight-threatening Diabetic Retinopathy.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

在4760例基线无威胁视力糖尿病视网膜病变(STDR)的中国2型糖尿病患者中,中位随访8.8年有172例发生STDR。仅血清AFABP与STDR发生独立相关(HR 1.28;95%CI 1.05-1.55;P=0.013),将其加入常规临床模型可改善预测STDR的c统计量(P<0.001)、净重分类指数(P=0.0027)和综合判别指数(P=0.033)。

要点

  • 血清AFABP与2型糖尿病患者发生威胁视力糖尿病视网膜病变独立相关(HR 1.28;95%CI 1.05-1.55;P=0.013)。
  • 发生STDR者基线血清AFABP和PEDF水平均显著高于未发生者(均P<0.001),但FGF21水平无显著差异。
  • 在基线无DR或轻度DR者中,AFABP加入常规临床模型可显著改善STDR预测的c统计量(P<0.001)。

核心结论

  • 在AFABP、FGF21和PEDF三种糖尿病相关生物标志物中,血清AFABP水平似乎是预测2型糖尿病发生STDR更具临床实用价值的生物标志物。

研究设计与样本

  • 研究纳入4760例基线无STDR的中国2型糖尿病患者,基线时测定血清AFABP、PEDF和FGF21水平,采用Cox回归分析这些生物标志物与发生STDR的关联。

主要发现

  • 在中位随访8.8年期间,4760例参与者中172例发生STDR。
  • 发生STDR者与未发生者的基线血清FGF21水平相当,但发生STDR者的基线血清AFABP和PEDF水平显著更高(均P<0.001)。
  • 在多变量Cox回归分析中,仅血清AFABP仍与发生STDR独立相关(HR 1.28;95%CI 1.05-1.55;P=0.013)。
  • 在基线无DR或轻度DR的参与者中,将血清AFABP加入包含糖尿病病程、血糖控制、白蛋白尿和基线DR状态等常规STDR危险因素的临床模型,可显著改善预测发生STDR的c统计量(P<0.001)、净重分类指数(P=0.0027)和综合判别指数(P=0.033)。

关键数值与推荐

  • 血清AFABP与发生STDR独立相关:HR 1.28;95%CI 1.05-1.55;P=0.013。
  • 发生STDR者基线AFABP和PEDF水平均显著高于未发生者(均P<0.001);两组基线FGF21水平无显著差异。
  • 在基线无DR或轻度DR者中,AFABP加入临床模型后c统计量改善P<0.001、净重分类指数改善P=0.0027、综合判别指数改善P=0.033。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adipocyte fatty acid-binding protein (AFABP), fibroblast growth factor 21 (FGF21), and pigment epithelium-derived factor (PEDF) are 3 diabetes-related biomarkers whose circulating levels had been shown to associate with nephropathy progression in Chinese patients with type 2 diabetes. OBJECTIVE: Here, we evaluated and compared their prospective associations with the development of sight-threatening DR (STDR), another important diabetic microvascular complication. METHODS: Baseline serum AFABP, PEDF, and FGF21 levels were measured in 4760 Chinese individuals with type 2 diabetes and without STDR at baseline. The associations of these biomarkers with incident STDR were analyzed using Cox regression analysis. RESULTS: Among these 4760 participants (mean diabetes duration of 11 years and ≥ 50% with nonproliferative DR at baseline), 172 participants developed STDR over a median follow-up of 8.8 years. Participants with incident STDR had comparable baseline serum FGF21 levels but significantly higher baseline serum AFABP and PEDF levels (both P < .001) than those without. However, in multivariable Cox regression analysis, only serum AFABP remained independently associated with incident STDR (hazard ratio 1.28; 95% CI, 1.05-1.55; P = .013). The addition of serum AFABP to a clinical model of conventional STDR risk factors including diabetes duration, glycemic control, albuminuria, and baseline DR status significantly improved the c statistics (P < .001), net reclassification index (P = .0027), and integrated discrimination index (P = .033) in predicting incident STDR among participants without DR or with mild DR at baseline. CONCLUSION: Among the 3 diabetes-related biomarkers, serum AFABP level appeared to be a more clinically useful biomarker for predicting incident STDR in type 2 diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lee CH, Lui DT, Cheung CY, et al. Circulating AFABP, FGF21, and PEDF Levels as Prognostic Biomarkers of Sight-threatening Diabetic Retinopathy. J Clin Endocrinol Metab. 2023. PMID: 36856742. doi:10.1210/clinem/dgad112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。